Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

TSPYL2 Is Important for G1 Checkpoint Maintenance upon DNA Damage

  • Kin Pong Tao,

    Affiliation Department of Paediatrics and Adolescent Medicine, Center of Reproduction, Development and Growth, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    ⨯
  • Sze Wan Fong,

    Affiliation Department of Paediatrics and Adolescent Medicine, Center of Reproduction, Development and Growth, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    ⨯
  • Zhihong Lu,

    Affiliation Department of Paediatrics and Adolescent Medicine, Center of Reproduction, Development and Growth, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    ⨯
  • Yick Pang Ching,

    Affiliation Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    ⨯
  • Kin Wang Chan,

    Affiliation Department of Paediatrics and Adolescent Medicine, Center of Reproduction, Development and Growth, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    ⨯
  • Siu Yuen Chan

    sychan@hkucc.hku.hk

    Affiliation Department of Paediatrics and Adolescent Medicine, Center of Reproduction, Development and Growth, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    ⨯

Abstract

Nucleosome assembly proteins play important roles in chromatin remodeling, which determines gene expression, cell proliferation and terminal differentiation. Testis specific protein, Y-encoded-like 2 (TSPYL2) is a nucleosome assembly protein expressed in neuronal precursors and mature neurons. Previous studies have shown that TSPYL2 binds cyclin B and inhibits cell proliferation in cultured cells suggesting a role in cell cycle regulation. To investigate the physiological significance of TSPYL2 in the control of cell cycle, we generated mice with targeted disruption of Tspyl2. These mutant mice appear grossly normal, have normal life span and do not exhibit increased tumor incidence. To define the role of TSPYL2 in DNA repair, checkpoint arrest and apoptosis, primary embryonic fibroblasts and thymocytes from Tspyl2 deficient mice were isolated and examined under unperturbed and stressed conditions. We show that mutant fibroblasts are impaired in G1 arrest under the situation of DNA damage induced by gamma irradiation. This is mainly attributed to the defective activation of p21 transcription despite proper p53 protein accumulation, suggesting that TSPYL2 is additionally required for p21 induction. TSPYL2 serves a biological role in maintaining the G1 checkpoint under stress condition.

Citation: Tao KP, Fong SW, Lu Z, Ching YP, Chan KW, Chan SY (2011) TSPYL2 Is Important for G1 Checkpoint Maintenance upon DNA Damage. PLoS ONE 6(6): e21602. https://doi.org/10.1371/journal.pone.0021602

Editor: Kerstin Borgmann, University Medical Center Hamburg-Eppendorf, Germany

Received: December 13, 2010; Accepted: June 6, 2011; Published: June 27, 2011

Copyright: © 2011 Tao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: The work described in this paper was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. HKU7323/03M and HKU2/02C) and partly by the Committee for Research and Conference Grants, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Nucleosome assembly proteins (NAPs) play important roles in the control of cell proliferation. They are divided into NAP, SET and TSPY families according to the amino acid conservation of the NAP domain. NAPs are involved in cell cycle control through regulating the transcription of cell cycle genes and through interaction with cyclins [1], [2]. Knockout of NAP1, the prototypic NAP family member, is embryonic lethal in Drosophila [3]. In yeast, NAP1 binds the mitotic cyclin Clb2 (homologue of cyclin B) and the protein kinase Gin4, thereby inducing cell cycle events [4], [5]. Testis-specific protein, Y-encoded (TSPY) also interacts with cyclin B and enhances cyclin B-CDK1 phosphorylation [6]. As the first TSPY family member being identified, TSPY accelerates cell proliferation, and is related to testicular and prostate cancers [7], [8], [9].

TSPY-like 2 (TSPYL2, also named as CDA1, CINAP, DENTT, NP79, Se20-4 and TSPX) is involved in cell cycle control, but in an opposite manner to the effect of TSPY. Whereas TSPY increases cyclin B-CDK1 activity, TSPYL2 inhibits its activity. The NAP domain performs the same function of binding cyclin B, but the acidic C-terminal tail in TSPYL2, and in another NAP member SET, is responsible for the inhibitory effect on cyclin B-CDK activity [6]. In agreement to this finding, SET overexpression retards cell cycle transition at G2/M [10]. By contrast the effect of TSPYL2 on cell cycle profile is not obvious although it can also arrest cell growth and inhibit DNA synthesis [11]. TSPYL2 may play a role in arresting cell growth upon DNA damage, as it can be induced by camptothecin, a topoisomerase inhibitor that induces DNA strand breaks [12]. TSPYL2 is also upregulated by TGFβ1, a cytokine that blocks the advancement from G1 to S phase, in responsive non-small-cell lung carcinoma cell lines [13]. Together with the fact that TSPYL2 can repress cyclin B-CDK1 activities, the major regulator complex during G2 to M phase progression, the data suggest that TSPYL2 can inhibit both G1/S and G2/M phases of the cell cycle. In agreement with the notion that TSPYL2 is a negative cell cycle regulator, TSPYL2 is silenced in glioma tissues, malignant lung tissues and certain lung tumor cell lines [14], [15]. Overexpression of TSPYL2 in human lung and breast cancer cell lines results in reduced growth potential [15]. Nevertheless, direct evidence of a physiological function of TSPYL2 in cell cycle control is lacking. Loss-of-function analysis is a powerful approach to address this question.

Loss-of-function of NAPs has been associated with human diseases. A frameshift mutation which results in truncation of the NAP domain in TSPYL1 is found in sudden infant death with dysgenesis of the testis syndrome [16]. Mouse embryos with deletion of the Nap1l2 gene exhibit neural tube defects closely resembling spina bifida and anencephaly, and NAP1L2 may be related to X-linked neural tube defects in humans [17], [18]. It is essential to validate the in vitro findings of TSPYL2 on cell cycle control and tumor suppression in vivo, as exemplified by elegant studies on various mouse mutants of p53 which demonstrate that in vivo findings can contradict the results in biochemical assays and cell line studies [19]. Here we report the generation and analysis of TSPYL2 deficient mice. The mutant mice generated are viable, fertile and do not exhibit increased tumor incidence. Ionizing radiation (IR) was employed for studying the DNA damage response without the complications of stalled transcription from ultraviolet light and topoisomerase inhibitors [20]. Primary cultures of mouse embryonic fibroblasts (MEFs) and thymocytes were isolated as they serve as well-established models for studying cell cycle control and apoptosis, respectively. We find that MEFs lacking functional Tspyl2 proliferate normally, but are impaired in G1 arrest following DNA damage. Despite proper stabilization of p53, induction of p21 transcription is specifically impaired. Our data demonstrate that loss of TSPYL2 function is not deleterious to the development of mice, and reveal the importance of TSPYL2 in the maintenance of G1 checkpoint under stress condition.

Materials and Methods

Ethics statement

Mouse experiments were approved and performed according to the instructions of Committee on the Use of Live Animals in Teaching and Research at the University of Hong Kong (approval ID: CULATR 1643-08).

Gene targeting, genotyping and mouse lines

In view of the potential importance of TSPYL2 in cell proliferation and brain development, a conditional knockout construct was designed. The neomycin resistance (neo) cassette with the phosphoglycerate kinase 1 promoter and polyA was franked by frt sites and inserted into intron 5 of Tspyl2. This allowed the removal of the neo cassette by flip recombinase so that it would not interfere with the transcription of Tspyl2. Exons 2 to 5, together with the neo cassette oriented in opposite direction to Tspyl2 transcription, was flanked by loxP sites. Exons 2 to 5, which encoded the NAP domain, could be conditionally deleted by expression of Cre recombinase. The targeting vector contained 4.0 kb of 5′ and 1.9 kb of 3′ homology arms. Embryonic stem (ES) cells were derived in house from 129Sv/Ev embryos by the Transgenic Core Facility at HKU, which also provided the service for electroporations and blastocyst injections. Homologous recombination in the G418 resistant ES clones was detected by Southern blot analysis using standard procedures. Probes for Southern blotting were derived from PCR, cloned and sequence verified. Chimeric mice were generated by injecting the targeted ES clones into C57BL/6 blastocysts, and mated to 129Sv/Ev mice. Germline transmission of the mutant Tspyl2 allele (Tspyl2m) was validated by PCR genotyping using primers binding Tspyl2 exon 5 (F5: 5′ CTACTATATGAGACGAGG) and neo (neo-R: 5′ TGAAGAACGAGATCAGCAGC). The wildtype Tspyl2 allele was detected using primers for exon 5 (F5) and exon 6 (R6: 5′ TGGTCAGGATCTTCACTGTC). The mouse line was called Tspyl2m and maintained in pure 129Sv/Ev background.

To remove exons 2 to 5 in Tspyl2m allele for the generation of Tspyl2 deleted mouse line, Tspyl2m/Y mice were mated to female transgenic mice that expressed Cre recombinase under the promoter for zona pellucida glycoprotein 3 [21]. The transgenic females originated from injected FVB/N oocytes and were subsequently bred into Swiss outbred background. Germline Cre-mediated excision of exons 2 to 5 was confirmed by PCR using primers for intron 1 (C1: 5′ CTTAGCATCTAGACCTACAGC) and exon 6 (R6). First generation offspring with the deleted allele (Tspyl2−) but not the Cre transgene as determined by PCR were used to establish the Tspyl2− line by brother to sister mating.

Northern Blot

Ten micrograms of RNA were resolved in 1% formaldehyde agarose gel. The blot was hybridized in Church buffer at 65°C with [αP32]-dCTP labeled probes covering nucleotide 545 - 1033 of Tspyl2 mRNA (NM_029836.3). The blot was washed twice with 2X SSC/0.1% SDS at 65°C for 10 minutes each, and then three times with 1X SSC/0.1% SDS at 65°C for 15 minutes each.

Brain histology and immunohistochemistry

Mice were intraperitoneally injected with 95 µg/g 5-bromo-2-deoxyuridine (BrdU) in saline for six consecutive days. Brains were collected after transcardial perfusion with 4% paraformaldehyde and fixed overnight. Brains were cryoprotected in 30% sucrose, and serial coronal sections of 40 µm were cut using a freezing microtome. After mounting, sections were incubated in citrate buffer (pH 6.0) at 85°C for 25 minutes. After 3 washes in PBS, sections were incubated with 37°C prewarmed 2M hydrochloric acid for 10 minutes, followed by 0.1 M borate buffer (pH 8.5) for 15 minutes for partial denaturation of DNA before commencing to conventional immnohistochemistry protocol. Staining was performed with anti-BrdU (Developmental Studies Hybridoma Bank) and Alexa Fluor® 488 goat anti-mouse IgG antibody (Invitrogen). The epiflorescence was observed using Axioplan-2 Carl Zeiss system, and the number of BrdU positive cells in the whole dentate gyrus was counted on one-in-six sections, omitting the outermost focal plane. The total number of BrdU positive cells being counted was multiplied by six to obtain the number for the entire dentate gyrus. For the lateral ventricle, the number of BrdU positive cells in corresponding region (Bregma level of −0.8 mm) was counted in one section, and the average was taken from three mice for each genotype.

Cell harvest, culture and treatments

MEFs were isolated from 12.5–14.5 day post-coitum embryos from heterozygous females mated with mutant males, and routinely passaged using the standard 3T3 protocol. MEFs were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplied with 10% fetal bovine serum (HyClone) at 37°C and 5% CO2. Single cell suspension of thymocytes was obtained by passing the dissected thymus from 2-months old mice through a 40 µm cell strainer (Falcon) followed by red blood cell lysis. Thymocytes were cultured overnight in Roswell Park Memorial Institute medium (Invitrogen) supplemented with 10% fetal bovine serum. For synchronization of MEFs in G1 or G2 phase, cells were incubated with 5 µg/ml aphidicolin (Biomol) or 80 ng/ml nocodazole (Sigma-Aldrich) for 12 hours. The IR experiments were performed by Gammacell 3000 Elan irradiator (MDS Nordion).

Flow cytometry

For cell cycle analysis, culture cells were collected by trypsinization, and fixed overnight at −20°C in 70% ethanol. Right before Flow analysis, cells were suspended in propidium iodide (PI) staining solution (Invitrogen) containing RNase for 15 minutes at room temperature. Cells were applied to EPICS Elite Flow Cytometer (Beckman Coulter) or LSRII (BD Biosciences). Cell cycle profiles were analyzed by ModFit® (Verity Software House). For analysis of apoptotic response, freshly isolated thymocytes from mice untreated or irradiated at 4 Gy were washed and stained with FITC tagged anti-CD4 and PE-Cy5 tagged anti-CD8 antibodies (BD Biosciences) for 1 hour, followed by Flow analysis. For Annexin V-PI (AVPI) experiment, thymocytes were collected from untreated mice, cultured overnight and subjected to 10 Gy IR. Cultures were collected at various time points for staining with BD Pharmingen™ Annexin V: FITC Apoptosis Detection Kit II according to manufacturer's instruction. Viability and apoptotic proportions were analyzed after collecting >20,000 cells with proper gating.

Immunocytochemistry and western blot

For immunocytochemistry, anti γ-H2AX (Upstate Biotech) and AlexaFlor® 594 anti-mouse IgG (Invitrogen) were used as primary and secondary antibodies. The primary antibodies used in western analysis included p53 (sc1311, Santa Cruz), acetyl-Lys379 p53 (#2570, Cell Signaling) and p21 (sc6246, Santa Cruz). Thirty µg of protein samples were loaded in parallel gels, and anti-actin (Sigma) was used as loading control. HRP-tagged secondary antibodies were detected using ECL Plus system (Amersham).

RT-PCR and real-time quantitative RT-PCR (qPCR)

RNA was isolated by Trizol (Invitrogen). After digestion with DNase I, 1 µg of RNA was reverse transcribed with SuperScript II (Invitrogen). One-tenth of the resulting cDNA sample was used for PCR. Semi-quantitative PCR was performed at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 45 seconds, annealing at 58°C for 30 seconds, and elongation at 72°C for 45 seconds. The final extension was 7 minutes. The primers used were listed as follows (5′ to 3′): F1: GGTTGCAGAGCCCAGCAG; R2: CACATTGGTTGATCAAGATTG; F2: GAGACCTCATCATCCAGCAT; R5: CCTCGTCTCATATAGTAG; F5; R6; Hprt-F: AACTGGAAAGAATGTCTTGATTG; Hprt-R: TCAAATCCAACAAAGTCTGGC; Tspyl1-F: ATGGAAACAGCTGAGCCCTT; Tspyl1-R: AAAGGCAGGCGGATTTCTGA; Tspyl2-QF: GGTCAAAGCATTCCTCAACC; Tspyl2-QR: GGTCCTGTACCTGAAGATTG; Tspyl3-F: GCGAGGCTTAGAATATCCAG; Tspyl3-R: AGGTGCAAAGCTACCTTGCA; Tspyl4-F: AGCTTCTCCAAAGCTCGTAG; Tspyl4-R: TGAGTGTTCCCAGGAGTCTT; Tspyl5-F: TTTGGGAGACTGGGGCATTG; Tspyl5-R: CAGAACACAGCAACCCTAAC. qPCR was performed using the iQ SYBR Green Supermix with ROX (Bio-Rad) on 7900HT System (Applied Biosystems) according to manufacturers' instruction. The expression of genes was calculated using the ΔΔCT method after normalization by Hprt (hypoxanthine guanine phosphoribosyl transferase), which showed a similar level of expression in all samples tested. Primers used were: Hprt-F, Hprt-R, Tspyl2-QF, Tspyl2-QR, p21-F: CCTGGTGATGTCCGACCTGTT; p21-R: GGGGAATCTTCAGGCCGCTC; Mdm2-F: TGAGACAGAAGAGAACACAG; Mdm2-R: CTTCCAATAGTCAGCTAAGG; Noxa-F: TGCCAGCAGACTTGAAGGAC; Noxa-R: GGAACCAAAAGCAAGCGAGC; 14-3-3σ-F: TGTCTGTCCATCCTCGCAGT; 14-3-3σ-R: CCTCCTCGTTGCTCTTCTGC; Bax-F: CTCAAGGCCCTGTGCACTAA; Bax-R: ATGTGGGGGTCCCGAAGTAG.

Statistical analysis

Student t-test was used for pairwise comparison, and two-way ANOVA followed by Bonferroni post-test were used for time-point qPCR analysis. All graphs were presented as the average ± SEM.

Results

Generation of Tspyl2 knockout mice

Tspyl2 deficient mice were generated using the targeting strategy shown in Fig. 1A. Two targeted clones were obtained after screening around one thousand ES colonies. The disruption of Tspyl2 was confirmed by Southern blot analysis with both 5′ and 3′ external probes (Fig. 1B). Chimeric mice were generated from blastocyst injection of targeted clones and crossed with wildtype 129Sv/Ev mice to generate the Tspyl2m line of pure genetic background. Genotypes of the pups were identified by PCR (Fig. 1C). Mice of various genotypes occurred in the correct Mendelian ratio. The Tspyl2 deleted line (Tspyl2 −) was generated by crossing the Tspyl2m line to outbred transgenic females expressing Cre and genotyped by PCR (Fig. 1C).

thumbnail
Download:
Figure 1. Generation of Tspyl2 knockout mice.

(A) Strategy for the target inactivation of Tspyl2. The targeting vector was constructed with neo expression cassette inserted into intron 5 of Tspyl2 in reverse orientation. The deleted allele was generated through Cre-mediated excision. Exons 1 and 6 were numbered, and the positions of external probes for Southern Blot and primers for PCR were marked. (B) Southern blot analysis using the 5′ and 3′ probes on KpnI and XbaI digested ES cell DNA showed expected fragment sizes. +/Y: wildtype; m/Y targeted mutant. (C) PCR genotyping of mice with PCR primers indicated. Typical results with DNA from wildtype male (+/Y), heterozygous Tspyl2+/m female (+/m), Tspyl2m/Y male (m/Y), Tspyl2+/− female (+/−), Tspyl2−/− female (−/−). (D) Left: RT-PCR with 35 cycles showed that insertion of neo eliminated the normal Tspyl2 transcript in Tspyl2m/Y brain; Right: RT-PCR with 30 cycles showed the correct deletion of Tspyl2 exons in Tspyl2−/Y. Primers were numbered according to exon binding sites. (E) RT-PCR indicated that m/Y brain had no upregulation of other family members of Tspyl genes.

https://doi.org/10.1371/journal.pone.0021602.g001

To characterize the Tspyl2m line, brain RNA samples were collected for analysis. RT-PCR with primers amplifying exons 1 to 2, 2 to 5 and 5 to 6 under extended cycle number of 35 revealed that the normal Tspyl2 transcript was eliminated in the Tspyl2m/Y mice. By contrast, the exon 2 to 5-deleted transcript was detected after 30 PCR cycles in Tspyl2−/Y mice (Fig. 1D). The data indicated that none of the previously reported transcript variants of mouse Tspyl2 was detectable in our two mouse lines [22]. To assess the potential compensatory effect from other TSPYL homologues, semi-quantitative RT-PCR was performed and no obvious upregulation of other TSPY family members was detected (Fig. 1E). In summary, the insertion of neo results in no stable Tspyl2 transcript being detected. Tspyl2m line was effectively a Tspyl2 knockout line. This agreed with the finding that homozygous and hemizygous mice in both Tspyl2m and Tspyl2 − lines were phenotypically normal. We performed our analysis on the Tspyl2m mice since they were in pure 129/SvEv genetic background.

Normal proliferation of neuronal precursor cells in Tspyl2m animals

TSPY is functional in humans and rats but not in mice [23]. To detect any species difference in the expression of its X-chromosome homologue TSPYL2, we checked its expression in mice. We previously reported that TSPYL2 is highly expressed in the human heart, brain and lung as revealed by Northern blotting [24]. High expression in the human heart was confirmed in two additional RNA samples (data not shown). In mice, high expression of Tspyl2 was detected in the brain but not the heart, and lower expression was detected in gonads (Fig. 2A). Tspyl2 expression in cerebral cortex, hippocampus, gonads and thymus was further compared by qPCR (Fig. 2B). Despite the expression of Tspyl2 in gonads, Tspyl2m/m and Tspyl2m/Y mice were of normal fertility. The morphology and size of Tspyl2 mutant brain were also comparable to that of wildtype littermates (Fig. 2C). Since it has been reported that TSPYL2 protein is detected in proliferating neuron precursors in the adult brain, we further investigated the consequence of gene knockout in the two brain areas where these cells are found [25]. The numbers of BrdU labeled neuronal precursors in dentate gyrus of the hippocampus and subependyma surrounding the lateral ventricles were similar between wildtype and mutant (Fig. 2D). The result shows that TSPYL2 is not essential for proliferation of neuron precursors in adults.

thumbnail
Download:
Figure 2. Tspyl2 mutant mice have normal proliferation of neuronal precursor cells.

(A) The expression pattern of Tspyl2 as revealed by northern blot. Equal loading of RNA was visualized by ethidium bromide staining. (B) qPCR analysis of Tspyl2 transcript in cerebral cortex, hippocampus (Hippo), testis, ovary and thymus in adult mice (n = 3–5). The relative expression of each tissue is expressed as the fold difference when compared with the thymus after normalization with Hprt. (C) Gross morphology of the brain dissected from wildtype (+/Y) and Tspyl2m/Y (m/Y) adult mice after perfusion fixation. (D) BrdU staining in dentate gyrus of hippocampus and lateral ventricle of 2 months old adult mice. Nuclei were stained by DAPI. Scale bar: 50 µm. The number of BrdU-positive cells was counted and shown on the right. Error bar: SEM.

https://doi.org/10.1371/journal.pone.0021602.g002

Tspyl2 mutant cells proliferate normally in culture

We wondered whether TSPYL2 behaved as a tumor suppressor, but we observed no spontaneous tumor development in our mutant mice and their life span was normal. To reveal any subtle role of TSPYL2 in cell proliferation, we used ES cells, primary MEFs and thymocytes as sources of normal cells. The expression of Tspyl2 in these cell types was measured by qPCR (Fig. 3A). The level of Tspyl2 expression in thymocytes was similar to that of thymus and set as 1 for comparison. ES cells and MEFs were subjected to PI based cell cycle analysis. As Tspyl2 is subjected to X-inactivation, heterozygous MEFs were excluded from analysis as random inactivation of Tspyl2 had occurred [26]. Using early passage cells, Tspyl2m/Y cells had a normal cell cycle profile, with no apoptotic or aneuploidy populations. The proportion of G1, S and G2/M cell populations was similar between wildtype and mutant from three independent experiments (Fig. 3B). In terms of senescence induced by culture stress, proliferation curves of wildtype and mutant MEFs were comparable and so did staining with senescence-associated β-galactosidase at passage 6 (Fig. 3C and data not shown). MEFs of both genotypes could be spontaneously immortalized. Next, early passage MEFs were synchronized with aphidicolin and nocodazole for transiently arresting cells in G1 and G2 phase, respectively. Re-entry into cell cycle through these checkpoints was measured by Flow cytometry (Fig. 3D). Again, Tspyl2 mutant MEFs showed normal advancement of cell cycle through both checkpoints after drug release.

thumbnail
Download:
Figure 3. Tspyl2 is dispensable for cell proliferation, but responsible for maintaining G1 checkpoint upon IR.

(A) qPCR analysis of Tspyl2 in MEFs, ES cells and thymocytes (Thy) (n = 3–4). The relative expression was expressed as the fold difference when compared with thymocytes after normalization with Hprt. (B) Rapidly growing ES cells and MEFs from wildtype (+/Y) and Tspyl2m/Y mutants (m/Y) were subjected to PI based cell cycle analysis. Cell populations from three independent experiments were summarized. Error bar: SEM. (C) MEFs harvested from wildtype (+/+ or +/Y, n = 4) and Tspyl2m mutants (m/Y or m/m, n = 5) were passaged under standard 3T3 protocol. Mutant and wildtype littermate MEFs proliferated at a similar rate after prolonged passaging. (D) MEFs were transiently treated with 5 µg/ml aphidicolin (unfilled) or 80 ng/ml nocodazole (black filled) for 12 hours for synchronization in G1 or G2 phase. Progression through cell cycle arrest after the release was measured by PI based Flow analysis. Numbers indicated on the right represent the hours released from synchronization treatment. (E) MEFs of passage 3 were exposed to 10 Gy IR and fixed at indicated time points for Flow analysis. Left: A representative result showing the cell cycle analysis using ModFit LT software. The calculated G1 and G2/M phases were represented by the two filled peaks, and the stripped portion in between corresponding to S phase. Right: The percentage of cells at S and G2/M from four independent experiments. Data were presented as mean ± SEM. A significantly higher percentage of mutant MEFs had entered S phase 24 hours after IR (*: p<0.05, n = 9 for each group).

https://doi.org/10.1371/journal.pone.0021602.g003

Tspyl2 mutant MEFs are defective in cell cycle arrest upon IR

Previous studies have shown that the transcription of TSPYL2 is activated upon treatment with camptothecin, a potent inducer of DNA strand breaks and inhibitor of topoisomerase I [12]. To further dissect the importance of Tspyl2 in cell cycle control, we induced DNA damage by IR. As ES cells are atypical in their response to DNA damage, only MEFs were used in this study as sources of non-transformed cells [27]. Early passage MEFs from wildtype and mutant embryos were subjected to 10 Gy IR for the induction of DNA double strand breaks. The proportion of S phase cells was determined by Flow cytometry (Fig. 3E). With functional checkpoint activation, normal MEFs undergo cell cycle arrest in response to DNA damage for DNA repair. Initiation of G1 and G2 checkpoints in mutant MEFs was normal, as indicated by a similar reduction in the percentage of S phase cells and increase in G2/M cells in wildtype and mutant MEFs at 8 hours after IR. The proportion of S phase cells in the wildtype remained low 24 hours after IR (35.9% ±6% of untreated, n = 9). By contrast, a significantly larger proportion of mutant MEFs had returned to S phase (77.51% ±17.3% of untreated, n = 9, p<0.05). This suggests a defect in the maintenance instead of initiation of the G1 checkpoint in the mutants.

Upstream of cell cycle arrest, histone H2AX is rapidly phosphorylated on serine 139 (γ-H2AX) which serves as a label of DNA damage loci [28]. Mutant MEFs had a normal time course of DNA repair as reflected by γ-H2AX counting. One hour after IR, wildtype and mutant MEFs were both able to trigger the H2AX phosphorylation, indicating normal recognition of DNA lesion. After 6 and 24 hours, the degree of lesion gradually decreased which indicated DNA repair. The recovery rate of DNA damage in the mutant MEFs was comparable with that of the wildtype controls (Fig. 4).

thumbnail
Download:
Figure 4. Normal DNA repair in Tspyl2 mutant MEFs.

MEFs from wildtype (+/Y) and Tspyl2m/Y mutant (m/Y) were irradiated at 10 Gy and collected at indicated time points for γ-H2AX immunocytochemistry for the detection of DNA damage foci. Scale bar: 200 µm. Cells (>200) with various number of lesion foci were counted and the degree of damage was summarized in the histogram on the bottom (n = 2 for each genotype). Data represented as mean value ± SEM from two independent experiments.

https://doi.org/10.1371/journal.pone.0021602.g004

Impaired p21 transcription upon IR in mutant MEFs

In the presence of DNA damage, there is a rapid accumulation of p53 and p21. In addition, acetylation of p53 promotes recruitment of coactivator such as CBP to the p21 promoter resulting in transcription activation [29]. While we observed no consistent difference in the basal level of p53 and p21 between wildtype and mutant MEFs, Lys379 of p53 was clearly acetylated upon IR. There was also an increase in the protein level of p53 and p21 after 10 Gy IR in both genotypes (Fig. 5A). As a member of NAPs, TSPYL2 is likely to regulate transcription of various checkpoint genes in DNA damage response. In support of this, Tspyl2 mutant MEFs were defective in p21 induction after exposure to 10 Gy IR (p<0.01). Thymocytes also showed impaired p21 transcription activation 4 hours after IR (p<0.05, Fig. 5B). Interestingly, the activation of other p53 target genes Mdm2, 14-3-3σ and the apoptotic genes Noxa and Bax was not significantly different between wildtype and mutant MEFs and thymocytes. The baseline level of expression of the above genes was similar between wildtype and mutant in the qPCR assay.

thumbnail
Download:
Figure 5. Impaired transcription of p21 downstream of p53 stabilization upon IR in mutant cells.

(A) Western Blot analysis of lysates from wildtype (+/Y) and Tspyl2m/Y mutant (m/Y) MEFs collected at indicated time points post 10 Gy IR to acetyl-p53 at Lys379, total p53 and p21. Actin served as a loading control. (B) qPCR analysis in MEFs (left panel) and thymocytes (right panel) after IR at 10 Gy. Transcription levels of indicated checkpoint genes were normalized by Hprt. The fold induction of individual gene is expressed as mean value ± SEM when compared to its untreated control (n = 5 per group). Data points showing asterisk indicate statistical significance between wildtype and mutants as revealed by Bonferroni post-test after 2-way ANOVA (*: p<0.05, **: p<0.01).

https://doi.org/10.1371/journal.pone.0021602.g005

Tspyl2 mutant thymocytes undergo apoptosis as control cells upon IR

Both cell cycle arrest and apoptosis are protective responses against DNA damage. In the case of thymocytes, more than 95% of cells are resting at the G0/G1 phase before IR and therefore they are not suitable for demonstrating cell cycle arrest. Upon IR, CD4/CD8 double-positive thymocytes undergo apoptosis, and this process is well-characterized to be dependent on the p53 activity, both in vitro and in vivo [30]. Thymocytes isolated from irradiated mice underwent IR-induced apoptosis, therefore the percentage of CD4/CD8 double-positive cells dropped (Fig. 6A). In wildtype, the percentage of CD4/CD8 double-positive cells dropped from 78.2% ±2.2% to 18.6% ±1.1% (n = 2). Tspyl2m mutant cells showed a similar reduction from 75.3% ±1.02% to 26.6% ±2.5% after IR (n = 2). To substantiate the in vivo findings, mutant and wildtype thymocytes were collected from non-irradiated mice and cultured overnight. After acute exposure to 10 Gy IR, they showed the same rate of cell death as measured by AVPI staining (Fig. 6B). Therefore, our data do not indicate a role of TSPYL2 in apoptosis.

thumbnail
Download:
Figure 6. Normal apoptotic response of Tspyl2 mutant thymocytes after IR.

(A) Thymocytes isolated from untreated (UT) wildtype and Tspyl2m/Y animals, or irradiated animals 24 hours after 4 Gy IR were stained for CD4 and CD8 and subjected to surface marker profiling by Flow cytometry. A representative result from one out of two animals is shown. +/Y: wildtype; m/Y mutant. Numbers indicate the percentage of CD4/CD8 double-positive cells in the top-right quadrant. (B) Result of AVPI experiment from a representative pair of thymocyte cultures. Thymocytes were cultured overnight after collection and subjected to 10 Gy IR. Cells were collected at various time points after IR and stained with AVPI. Bottom: Percentage of viable (AV−, PI−), early apoptotic (AV+, PI−) and late apoptotic (AV+, PI+) cells from two independent experiments (filled square: Tspyl2+/Y, open circle: Tspyl2m/Y, n = 5).

https://doi.org/10.1371/journal.pone.0021602.g006

Discussion

As a novel NAP identified in a number of screens, TSPYL2 is shown to play a role in cell proliferation [6], [11], [12], TGF-β1 signaling pathway [15], [31], [32] and synaptic function [25], [33], [34]. Very little is known about the physiological functions of NAPs and we address this question through gene targeting in mice. This is the first report on mutants amongst the TSPY family. While the loss of TSPYL2 has no deleterious effects in mice we show there is a clear cell cycle defect under the situation of DNA damage. Our results indicate that TSPYL2 is required for cell cycle maintenance in stress condition.

Using MEFs derived from the mutant mice, we are able to reveal the role of TSPYL2 in cell cycle regulation. Tspyl2 mutant MEFs are defective in G1 cell cycle arrest upon IR. More specifically, initiation of checkpoint response is normal as indicated by proper triggering of the DNA damage response, accumulation of p53 and p21 protein, and reduction in S phase cells within 8 hours after IR. Failure in maintaining the checkpoint arrest in mutant cells is in agreement with the molecular finding of impaired transcriptional activation of p21. Upon stressful stimuli such as DNA lesions and survival crisis, transcription of p21 is activated which serves as the key initiator for cell cycle arrest. As p21 mutant MEFs are also defective in blocking S phase entry after IR but have normal mitotic spindle checkpoint induced by microtubule inhibitor, we attribute the impaired G1 checkpoint in TSPYL2 mutant MEFs mainly to impaired p21 induction. Other similarities between Tspyl2 and p21 knockout mice include the absence of gross developmental abnormalities or spontaneous malignancies. Besides, apoptosis in thymocytes is not affected [35]. Our data suggest that TSPYL2 is a new player in transcription activation of p21 upon IR.

What causes the specific effect of TSPYL2 on the transcription of p21 but not several other p53 target genes being tested? In a previous report, reporter activity of the p21 promoter is significantly activated by cotransfection of TSPYL2 expression plasmid in HeLa cells. This is linked to the increased stability of p53 protein [12]. Our data indicate that in MEFs, p53 stabilization upon IR is normal even without functional TSPYL2. Concerning the role of TSPYL2, it has been proposed that binding of NAPs to nucleosomal DNA facilitates the binding of transcription factors to their DNA binding site [36]. NAPs also strengthen the binding between transcription factor and p300/CBP and this leads to transcription activation [2]. Another possibility is NAPs perform their task of nucleosome displacement after being recruited to the transcription complex [37]. In any case, TSPYL2 is likely to recognize specific partner other than p300/CBP to fine tune the transcription activity of specific p53 target genes.

G1 checkpoint is vital for delaying cell cycle progression upon DNA damage, allowing more time for DNA repair and preventing the replication of mutated template. Tspyl2 knockout MEFs showed defective cell cycle arrest, but Tspyl2 mutant animals did not suffer a higher tendency of tumorigenesis when compared with wildtype littermates throughout eighteen months of observation. Furthermore, mutant mice irradiated at 4 Gy did not develop tumors after 6 months (data not shown). Due to the intricate network of processes to control cell proliferation, there is potential compensatory effect by other tumor suppressors. Very often the cell cycle defects are revealed only by introduction of additional mutation in another gene of the same family or working in the same pathway, such as that observed in p21, atm double mutants and Chk1, Chk2 double mutants [38], [39]. In addition, the genetic background of the mutant animals can affect the tumorigenic observations [40]. We conclude that TSPYL2 is a new player in controlling the cell cycle upon DNA damage.

Acknowledgments

We are grateful to Drs. Zhongjun Zhou and Baohua Liu for advice and reagents for studies on MEFs; Profs. YS Chan, KF So and Dr. Benson Lau for help in histomorphological studies; Prof. CC Hui, University of Toronto for useful comments on the manuscript; Ms. Priscilla Mak for technical support. We thank Shun Tak District Min Yuen Tong of Hong Kong for donating 7900HT Fast Real-time PCR system, and Children's Cancer Foundation for donating LSRII Flow Cytometer. Z. Lu is a Dr. Cheng Yu Tung Fellow.

Author Contributions

Conceived and designed the experiments: KPT YPC SYC. Performed the experiments: KPT SWF ZL KWC SYC. Analyzed the data: KPT SWF YPC SYC. Contributed reagents/materials/analysis tools: YPC SYC. Wrote the paper: KPT SYC.

References

  1. 1. Kellogg DR, Kikuchi A, Fujii-Nakata T, Turck CW, Murray AW (1995) Members of the NAP/SET family of proteins interact specifically with B-type cyclins. J Cell Biol 130: 661–673.
  2. 2. Shikama N, Chan HM, Krstic-Demonacos M, Smith L, Lee CW, et al. (2000) Functional interaction between nucleosome assembly proteins and p300/CREB-binding protein family coactivators. Mol Cell Biol 20: 8933–8943.
  3. 3. Lankenau S, Barnickel T, Marhold J, Lyko F, Mechler BM, et al. (2003) Knockout targeting of the Drosophila nap1 gene and examination of DNA repair tracts in the recombination products. Genetics 163: 611–623.
  4. 4. Altman R, Kellogg D (1997) Control of mitotic events by Nap1 and the Gin4 kinase. J Cell Biol 138: 119–130.
  5. 5. Kellogg DR, Murray AW (1995) NAP1 acts with Clb1 to perform mitotic functions and to suppress polar bud growth in budding yeast. J Cell Biol 130: 675–685.
  6. 6. Li Y, Lau YF (2008) TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene 27: 6141–6150.
  7. 7. Oram SW, Liu XX, Lee TL, Chan WY, Lau YF (2006) TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 6: 154.
  8. 8. Lau YF, Lau HW, Komuves LG (2003) Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res 101: 250–260.
  9. 9. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, et al. (1996) Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 5: 1801–1807.
  10. 10. Canela N, Rodriguez-Vilarrupla A, Estanyol JM, Diaz C, Pujol MJ, et al. (2003) The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem 278: 1158–1164.
  11. 11. Chai Z, Sarcevic B, Mawson A, Toh BH (2001) SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J Biol Chem 276: 33665–33674.
  12. 12. Tu Y, Wu W, Wu T, Cao Z, Wilkins R, et al. (2007) Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways. J Biol Chem 282: 11722–11731.
  13. 13. Ozbun LL, You L, Kiang S, Angdisen J, Martinez A, et al. (2001) Identification of differentially expressed nucleolar TGF-beta1 target (DENTT) in human lung cancer cells that is a new member of the TSPY/SET/NAP-1 superfamily. Genomics 73: 179–193.
  14. 14. Kim TY, Zhong S, Fields CR, Kim JH, Robertson KD (2006) Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 66: 7490–7501.
  15. 15. Kandalaft LE, Zudaire E, Portal-Nunez S, Cuttitta F, Jakowlew SB (2008) Differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) exhibits an inhibitory role on tumorigenesis. Carcinogenesis 29: 1282–1289.
  16. 16. Puffenberger EG, Hu-Lince D, Parod JM, Craig DW, Dobrin SE, et al. (2004) Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proc Natl Acad Sci U S A 101: 11689–11694.
  17. 17. Rogner UC, Spyropoulos DD, Le Novere N, Changeux JP, Avner P (2000) Control of neurulation by the nucleosome assembly protein-1-like 2. Nat Genet 25: 431–435.
  18. 18. Rogner UC, Danoy P, Matsuda F, Moore GE, Stanier P, et al. (2002) SNPs in the CpG island of NAP1L2: a possible link between DNA methylation and neural tube defects? Am J Med Genet 110: 208–214.
  19. 19. Olsson A, Manzl C, Strasser A, Villunger A (2007) How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 14: 1561–1575.
  20. 20. Ljungman M, Zhang F, Chen F, Rainbow AJ, McKay BC (1999) Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18: 583–592.
  21. 21. Lewandoski M, Wassarman KM, Martin GR (1997) Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line. Curr Biol 7: 148–151.
  22. 22. Delbridge ML, Longepied G, Depetris D, Mattei MG, Disteche CM, et al. (2004) TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X - implications for Y chromosome evolution. Chromosome Res 12: 345–356.
  23. 23. Mazeyrat S, Mitchell MJ (1998) Rodent Y chromosome TSPY gene is functional in rat and non-functional in mouse. Hum Mol Genet 7: 557–562.
  24. 24. Sun G, Yuen Chan S, Yuan Y, Wang Chan K, Qiu G, et al. (2002) Isolation of differentially expressed genes in human heart tissues. Biochim Biophys Acta 1588: 241–246.
  25. 25. Lin CW, Huang TN, Wang GS, Kuo TY, Yen TY, et al. (2006) Neural activity- and development-dependent expression and distribution of CASK interacting nucleosome assembly protein in mouse brain. J Comp Neurol 494: 606–619.
  26. 26. Tsuchiya KD, Greally JM, Yi Y, Noel KP, Truong JP, et al. (2004) Comparative sequence and x-inactivation analyses of a domain of escape in human xp11.2 and the conserved segment in mouse. Genome Res 14: 1275–1284.
  27. 27. Aladjem MI, Spike BT, Rodewald LW, Hope TJ, Klemm M, et al. (1998) ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 8: 145–155.
  28. 28. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858–5868.
  29. 29. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, et al. (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8: 1243–1254.
  30. 30. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847–849.
  31. 31. Ozbun LL, You L, Kiang S, Angdisen J, Martinez A, et al. (2001) Identification of differentially expressed nucleolar TGF-beta1 target (DENTT) in human lung cancer cells that is a new member of the TSPY/SET/NAP-1 superfamily. Genomics 73: 179–193.
  32. 32. Pham Y, Tu Y, Wu T, Allen TJ, Calkin AC, et al. (2010) Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis. Diabetologia 53: 170–179.
  33. 33. Wang GS, Hong CJ, Yen TY, Huang HY, Ou Y, et al. (2004) Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron 42: 113–128.
  34. 34. Kristiansen LV, Patel SA, Haroutunian V, Meador-Woodruff JH (2010) Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 64: 495–502.
  35. 35. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684.
  36. 36. Walter PP, Owen-Hughes TA, Cote J, Workman JL (1995) Stimulation of transcription factor binding and histone displacement by nucleosome assembly protein 1 and nucleoplasmin requires disruption of the histone octamer. Mol Cell Biol 15: 6178–6187.
  37. 37. Luebben WR, Sharma N, Nyborg JK (2010) Nucleosome eviction and activated transcription require p300 acetylation of histone H3 lysine 14. Proc Natl Acad Sci U S A 107: 19254–19259.
  38. 38. Wang YA, Elson A, Leder P (1997) Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci U S A 94: 14590–14595.
  39. 39. Niida H, Murata K, Shimada M, Ogawa K, Ohta K, et al. (2010) Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J 29: 3558–3570.
  40. 40. Harvey M, McArthur MJ, Montgomery CA Jr, Bradley A, Donehower LA (1993) Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J 7: 938–943.